Difference between revisions of "Template:Analgesics"
Jump to navigation
Jump to search
blackwiki>Miserlou (Add NFEPP) |
m (261 revisions imported) |
||
| (20 intermediate revisions by 10 users not shown) | |||
| Line 31: | Line 31: | ||
* [[Hydromorphone]] | * [[Hydromorphone]] | ||
* [[Nicocodeine]] | * [[Nicocodeine]] | ||
| − | * [[ | + | * [[Nicodicodine]] |
* [[Nicomorphine]] | * [[Nicomorphine]] | ||
* [[Oxycodone]] ([[oxycodone/paracetamol|+paracetamol]], [[oxycodone/aspirin|+aspirin]], [[oxycodone/ibuprofen|+ibuprofen]], [[oxycodone/naloxone|+naloxone]], [[oxycodone/naltrexone|+naltrexone]]) | * [[Oxycodone]] ([[oxycodone/paracetamol|+paracetamol]], [[oxycodone/aspirin|+aspirin]], [[oxycodone/ibuprofen|+ibuprofen]], [[oxycodone/naloxone|+naloxone]], [[oxycodone/naltrexone|+naltrexone]]) | ||
| Line 39: | Line 39: | ||
| group3 = Synthetic | | group3 = Synthetic | ||
| list3 = | | list3 = | ||
| + | * [[Alfentanil]] | ||
* [[Prodine|Alphaprodine]] | * [[Prodine|Alphaprodine]] | ||
* [[Anileridine]] | * [[Anileridine]] | ||
* [[Butorphanol]] | * [[Butorphanol]] | ||
| + | * [[Carfentanil]] | ||
* [[Dextromoramide]] | * [[Dextromoramide]] | ||
* [[Dextropropoxyphene]] | * [[Dextropropoxyphene]] | ||
* [[Dezocine]] | * [[Dezocine]] | ||
| − | * [[Fentanyl]] ([[fentanyl/fluanisone|+fluanisone]]) | + | * [[Dipipanone]] |
| + | * [[Fentanyl]]<sup>#</sup> ([[fentanyl/fluanisone|+fluanisone]]) | ||
* [[Ketobemidone]] | * [[Ketobemidone]] | ||
* [[Levorphanol]] | * [[Levorphanol]] | ||
| + | * [[Lofentanil]] | ||
* [[Meptazinol]] | * [[Meptazinol]] | ||
| − | * [[Methadone]] | + | * [[Methadone]]<sup>#</sup> |
* [[Nalbuphine]] | * [[Nalbuphine]] | ||
* [[NFEPP]] | * [[NFEPP]] | ||
* [[Pentazocine]] | * [[Pentazocine]] | ||
| − | * [[Pethidine]] | + | * [[Pethidine|Pethidine (meperidine)]] |
* [[Phenadoxone]] | * [[Phenadoxone]] | ||
* [[Phenazocine]] | * [[Phenazocine]] | ||
| Line 59: | Line 63: | ||
* [[Piritramide]] | * [[Piritramide]] | ||
* [[Propiram]] | * [[Propiram]] | ||
| + | * [[Remifentanil]] | ||
| + | * [[Sufentanil]] | ||
* [[Tapentadol]] | * [[Tapentadol]] | ||
* [[Tilidine]] | * [[Tilidine]] | ||
| Line 75: | Line 81: | ||
* [[Propacetamol]]<sup>‡</sup> | * [[Propacetamol]]<sup>‡</sup> | ||
| − | | group3 = [[ | + | | group3 = [[Nonsteroidal anti-inflammatory drug|NSAIDs]] |
| list3 = {{Navbox|child | | list3 = {{Navbox|child | ||
| liststyle = width: auto; | | liststyle = width: auto; | ||
| Line 111: | Line 117: | ||
* [[Valdecoxib]] <sup>‡</sup> | * [[Valdecoxib]] <sup>‡</sup> | ||
| − | | group5 = [[Fenamate]]s | + | | group5 = [[Fenamic acid|Fenamate]]s |
| list5 = | | list5 = | ||
* [[Meclofenamic acid]] | * [[Meclofenamic acid]] | ||
| Line 151: | Line 157: | ||
* [[Tetrahydrocannabinol|Tetrahydrocannabinol (dronabinol)]] | * [[Tetrahydrocannabinol|Tetrahydrocannabinol (dronabinol)]] | ||
| − | | group5 = [[ | + | | group5 = [[Channel modulator|Ion channel<br />modulator]]s |
| list5 = {{Navbox|child | | list5 = {{Navbox|child | ||
| liststyle = width: auto; | | liststyle = width: auto; | ||
| Line 157: | Line 163: | ||
| group1 = [[Calcium channel blocker|Calcium blockers]] | | group1 = [[Calcium channel blocker|Calcium blockers]] | ||
| list1 = | | list1 = | ||
| + | * [[Alcohol (drug)|Alcohol (ethanol)]] | ||
* [[Gabapentin]] | * [[Gabapentin]] | ||
* [[Gabapentin enacarbil]] | * [[Gabapentin enacarbil]] | ||
| + | * [[Mirogabalin]] | ||
* [[Pregabalin]] | * [[Pregabalin]] | ||
* [[Ziconotide]] | * [[Ziconotide]] | ||
| Line 174: | Line 182: | ||
* [[Funapide]]<sup>§</sup> | * [[Funapide]]<sup>§</sup> | ||
* [[PF-05089771]]<sup>§</sup> | * [[PF-05089771]]<sup>§</sup> | ||
| − | |||
| group3 = [[Potassium channel opener|Potassium openers]] | | group3 = [[Potassium channel opener|Potassium openers]] | ||
| list3 = | | list3 = | ||
| − | * [[Flupirtine]] | + | * [[Flupirtine]]<sup>‡</sup> |
}} | }} | ||
| − | | group6 = [[Myorelaxant]]s | + | | group6 = [[Muscle relaxant|Myorelaxant]]s |
| list6 = | | list6 = | ||
* [[Carisoprodol]] | * [[Carisoprodol]] | ||
| Line 193: | Line 200: | ||
| group7 = Others | | group7 = Others | ||
| list7 = | | list7 = | ||
| + | * [[Analgesic adjuvant]] | ||
| + | * [[Analgecine]] | ||
* [[Camphor]] | * [[Camphor]] | ||
* [[Capsaicin]] | * [[Capsaicin]] | ||
| Line 204: | Line 213: | ||
| list8 = | | list8 = | ||
| − | + | {{PharmNavFootnote}} | |
}}<noinclude> | }}<noinclude> | ||
| − | {{ | + | {{Documentation}} |
| − | |||
</noinclude> | </noinclude> | ||
Latest revision as of 14:48, 21 October 2020
Initial visibility: currently defaults to collapsed
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Analgesics|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Analgesics|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Analgesics|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to collapsed.
| The above documentation is transcluded from Template:Analgesics/doc. (edit | history) Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages. Please add categories to the /doc subpage. Subpages of this template. |